Publications Repository - Helmholtz-Zentrum Dresden-Rossendorf

Glutathione (GSH), a ubiquitous intracellular reducing tripeptide, is able to reduce hexavalent uranium, U(VI), to its tetravalent form, U(IV), in aqueous media in vitro, inducing the formation of nanocrystalline mixed-valence uranium oxide particles. After initial reduction to U(V) and subsequent dismutation, yielded U(IV) rapidly hydrolyses at near-neutral conditions forming 2–5 nm sized nanoparticles. The latter further aggregate to 20–40 nm chain-like building blocks that finally arrange as network-like structures.